Literature DB >> 25596135

In vitro study of the neuropathic potential of the organophosphorus compounds trichlorfon and acephate.

Laís S Fernandes1, Guilherme L Emerick2, Neife Aparecida G dos Santos1, Eloísa Silva de Paula1, Fernando Barbosa1, Antonio Cardozo dos Santos3.   

Abstract

Organophosphorus-induced delayed neuropathy (OPIDN) is a central and peripheral distal axonopathy characterized by ataxia and paralysis. Trichlorfon and acephate are two organophosphorus compounds (OPs) used worldwide as insecticide and which cause serious effects to non-target species. Despite that, the neuropathic potential of these OPs remains unclear. The present study addressed the neurotoxic effects and the neuropathic potential of trichlorfon and acephate in SH-SY5Y human neuroblastoma cells, by evaluating inhibition and aging of neuropathy target esterase (NTE), inhibition of acetylcholinesterase (AChE), neurite outgrowth, cytotoxicity and intracellular calcium. Additionally, the effects observed were compared to those of two well-studied OPs: mipafox (known as neuropathic) and paraoxon (known as non-neuropathic). Trichlorfon and mipafox presented the lowest percentage of reactivation of inhibited NTE and the lowest ratio IC50 NTE/IC50 AChE. Moreover, they caused inhibition and aging of at least 70% of the activity of NTE at sub-lethal concentrations. All these effects have been associated with induction of OPIDN. When assayed at these concentrations, trichlorfon and mipafox reduced neurite outgrowth and increased intracellular calcium, events implicated in the development of OPIDN. Acephate caused effects similar to those caused by paraoxon (non-neuropathic OP) and was only able to inhibit 70% of NTE activity at lethal concentrations. These findings suggest that trichlorfon is potentially neuropathic, whereas acephate is not.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acephate; Acetylcholinesterase (AChE); Neuropathy target esterase (NTE); Organophosphorus compounds; Organophosphorus-induced delayed neuropathy (OPIDN); Trichlorfon

Mesh:

Substances:

Year:  2015        PMID: 25596135     DOI: 10.1016/j.tiv.2015.01.001

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  6 in total

1.  A mechanism-based 3D-QSAR approach for classification and prediction of acetylcholinesterase inhibitory potency of organophosphate and carbamate analogs.

Authors:  Sehan Lee; Mace G Barron
Journal:  J Comput Aided Mol Des       Date:  2016-04-07       Impact factor: 3.686

Review 2.  Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown.

Authors:  Samantha J Merwin; Teresa Obis; Yanelli Nunez; Diane B Re
Journal:  Arch Toxicol       Date:  2017-01-09       Impact factor: 5.153

3.  Dissipation kinetics, safety evaluation, and preharvest interval assessment of trichlorfon application on rice.

Authors:  Xiao-Jun Chen; Ya-jun Ren; Zhi-yuan Meng; Chun-liang Lu; Hao-tian Gu; Yi-qing Zhuang
Journal:  Environ Monit Assess       Date:  2016-04-05       Impact factor: 2.513

4.  Tissue Metabolism, Hematotoxicity, and Hepatotoxicity of Trichlorfon in Carassius auratus gibelio After a Single Oral Administration.

Authors:  Jianfei Lu; Minli Zhang; Liqun Lu
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

5.  A Perspective of Molecular Cytogenomics, Toxicology, and Epigenetics for the Increase of Heterochromatic Regions and Retrotransposable Elements in Tambaqui (Colossoma macropomum) Exposed to the Parasiticide Trichlorfon.

Authors:  Maria Dos Santos Costa; Hallana Cristina Menezes da Silva; Simone Cardoso Soares; Ramon Marin Favarato; Eliana Feldberg; Ana Lúcia Silva Gomes; Roberto Ferreira Artoni; Daniele Aparecida Matoso
Journal:  Animals (Basel)       Date:  2022-07-31       Impact factor: 3.231

6.  Activation of Neuregulin 1/ErbB Signaling Is Involved in the Development of TOCP-Induced Delayed Neuropathy.

Authors:  Hai-Yang Xu; Pan Wang; Ying-Jian Sun; Ming-Yuan Xu; Li Zhu; Yi-Jun Wu
Journal:  Front Mol Neurosci       Date:  2018-04-23       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.